introduct
pulmonari
embol
pe
diseas
high
mortal
morbid
rate
pathogenesi
pe
remain
still
unclear
aim
investig
gene
express
differ
complement
system
peripher
blood
mononuclear
cell
pbmc
patient
symptomat
pe
control
method
twenti
case
pe
patient
twenti
sex
age
match
control
recruit
studi
human
cdna
microarray
analysi
use
detect
gene
express
differ
complement
system
two
group
result
express
twentyon
gene
encod
complement
compon
detect
pe
patient
express
gene
encod
factor
p
significantli
greater
p
b
control
mannosebind
lectin
mbl
mannanbind
lectin
serin
peptidas
mrna
lower
p
b
control
express
seven
gene
encod
complement
receptor
examin
pe
patient
integrin
integrin
mrna
significantli
upregul
p
b
compar
control
seven
gene
encod
complement
regul
examin
mrna
express
significantli
upregul
p
b
wherea
factor
mrna
significantli
downregul
p
b
pe
patient
control
conclus
pe
patient
mrna
express
complement
compon
receptor
regul
unbalanc
suggest
dysfunct
andor
defici
complement
system
lead
decreas
function
macinduc
cell
lysi
pe
patient
final
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
c
l
c
e
h
r
r
e
fig
mrna
express
complement
receptor
regul
b
pbmc
pe
patient
control
p
b
p
b
deep
vein
thrombosi
dvt
pulmonari
embol
pe
collect
known
venou
thromboembol
vte
pe
categor
acut
pulmonari
embol
ape
chronic
thromboembol
pulmonari
hypertens
cteph
pe
major
health
problem
high
incid
mortal
misdiagnosi
miss
diagnosi
rate
vte
risk
factor
classifi
either
acquir
inherit
acquir
american
colleg
chest
physician
accp
publish
guidelin
prevent
diagnosi
treatment
vte
surgic
patient
sinc
nine
issu
publish
far
howev
incid
symptomat
vte
increas
instead
reduc
probabl
pathogenesi
vte
still
unclear
smeeth
et
al
report
acut
infect
associ
increas
risk
vte
previous
report
vte
found
multipl
organ
includ
lung
spleen
pancrea
kidney
adren
gland
patient
die
sever
acut
respiratori
syndrom
addit
previou
studi
show
significantli
downregul
mrna
express
gene
associ
natur
killer
nk
cell
cell
patient
symptomat
pe
declin
cellular
immun
function
patient
acut
pe
cteph
respect
previou
studi
indic
occurr
progress
symptomat
pe
close
associ
innat
adapt
immun
complement
system
play
import
role
innat
adapt
immun
system
defens
pathogen
compos
differ
protein
includ
complement
compon
receptor
regul
clinic
practic
hard
detect
level
protein
complement
system
current
therefor
present
studi
human
microarray
analysi
use
examin
mrna
express
complement
compon
receptor
regul
pbmc
isol
thrombosi
research
symptomat
pe
patient
control
design
vitro
studi
investig
chang
function
complement
system
patient
symptomat
pe
twenti
patient
pe
recruit
tongji
hospit
tongji
univers
diagnosi
pe
requir
two
follow
three
criteria
select
pulmonari
angiographi
show
pulmonari
arteri
obstruct
fill
defect
lung
ventilationperfus
scan
show
singl
multipl
blood
perfus
defect
normal
abnorm
ventil
vq
match
clinic
diagnosi
risk
factor
pe
cardiovascular
diseas
exclud
clinic
perform
electrocardiogram
chest
film
arteri
blood
ga
analysi
suggest
hypoxemia
hypocapnia
ddimer
detect
echocardiographi
chest
comput
tomographi
support
pe
diagnosi
chose
twenti
patient
admit
depart
cardiolog
time
control
studi
patient
divid
two
group
pe
patient
group
patient
male
femal
mean
age
yr
includ
case
cteph
control
group
patient
male
femal
without
pe
dvt
arteri
thrombosi
congenit
coagul
abnorm
mean
age
mean
age
yr
match
sex
age
pe
group
signific
statist
differ
age
two
group
p
clinic
trial
approv
ethic
committe
tongji
univers
inform
consent
form
also
obtain
agil
whole
human
genom
oligo
microarray
purchas
agil
usa
microarray
compos
spot
includ
gene
transcript
neg
control
spot
posit
control
spot
blank
spot
function
gene
microarray
known
patient
subject
microarray
analysi
total
rna
isol
ml
peripher
blood
sampl
anticoagul
edta
drawn
patient
suspect
pe
immedi
admit
hospit
patient
without
pe
respect
mononuclear
cell
obtain
densiti
gradient
centrifug
ficol
solut
remain
red
blood
cell
destroy
erythrocyt
lysi
buffer
qiagen
hilden
germani
total
mononuclear
cell
rna
extract
trizol
invitrogen
carlsbad
usa
purifi
qiagen
rneasi
column
qiagen
hilden
germani
accord
manufactur
instruct
isol
total
rna
testifi
quantifi
mean
nanodrop
spectrophotomet
nanodrop
technolog
cambrig
uk
total
rna
revers
transcrib
doubl
strand
cdna
purif
vitro
amplif
perform
agil
low
rna
input
linear
amplif
kit
agil
pal
alto
usa
modifi
utp
aautp
utp
use
replac
utp
integr
aautp
interact
nh
ester
form
fluoresc
product
use
hybrid
integr
rate
fluoresc
determin
spectrophotomet
hybrid
mixtur
prepar
agil
oligonucleotid
microarray
situ
hybrid
plu
kit
ng
fluoresc
product
fragment
hybrid
conduct
human
wholegenom
oligochip
agil
technolog
h
rpm
hybrid
chip
wash
agil
gene
express
wash
buffer
accord
manufactur
instruct
origin
signal
obtain
agil
scanner
featur
extract
softwar
standard
origin
signal
carri
rma
standard
method
standard
signal
valu
use
screen
differenti
express
gene
three
differenti
gene
microarray
select
express
confirm
rtpcr
among
gene
differenti
express
gene
randomli
select
gene
hous
keep
gene
gapdh
subject
rtpcr
rel
express
express
express
target
gene
normal
gapdh
melt
curv
method
use
compar
differ
express
control
group
pe
group
result
rtpcr
consist
microarray
analysi
independentsampl
test
use
compar
mrna
level
sampl
pe
patient
control
statist
test
perform
use
spss
p
valu
consid
signific
test
test
equal
varianc
perform
varianc
equal
test
result
would
correct
result
show
mrna
express
complement
earli
compon
includ
factor
b
factor
factor
p
mbl
pbmc
patient
pe
control
detect
fig
pbmc
pe
patient
express
gene
encod
factor
p
significantli
greater
p
b
control
gene
express
mbl
lower
p
b
pbmc
pe
patient
compar
control
gene
express
complement
late
compon
includ
pbmc
pe
patient
control
also
detect
fig
pe
patient
mrna
express
significantli
upregul
p
b
wherea
significantli
downregul
p
b
compar
control
result
show
mrna
express
complement
receptor
includ
integrin
integrin
integrin
pbmc
pe
patient
control
examin
fig
consist
integrin
integrin
compris
integrin
integrin
pe
patient
express
seven
gene
mrna
upregul
mrna
express
integrin
integrin
significantli
upregul
p
b
compar
control
gene
express
complement
regul
bind
protein
bind
protein
factor
h
factor
pbmc
pe
patient
control
detect
fig
mrna
significantli
upregul
p
b
factor
mrna
significantli
downregul
p
b
pbmc
pe
patient
control
complement
system
import
compon
innat
immun
howev
also
play
import
role
adapt
immun
system
defend
pathogen
three
distinct
pathway
activ
complement
system
classic
lectin
altern
pathway
share
common
termin
pathway
lead
format
membran
attack
complex
mac
form
transmembran
pore
target
cell
membran
caus
cell
lysi
death
detect
earli
complement
compon
three
complement
pathway
two
group
found
factor
p
mrna
significantli
upregul
mbl
mrna
significantli
downregul
pe
patient
compar
control
fig
upregul
mrna
pe
patient
suggest
exist
pathogen
invas
lead
activ
classic
pathway
mannosebind
lectin
mbl
ficolin
bind
carbohydr
surfac
pathogen
mblassoci
serin
proteas
masp
activ
lectin
pathway
activ
previou
studi
shown
peopl
mbl
defici
suscept
varieti
infect
especi
adapt
immun
immatur
therefor
downregul
mbl
mrna
pe
patient
indic
defici
declin
lectin
pathway
function
pe
patient
initi
format
mac
consist
multipl
molecul
recent
research
shown
defici
increas
suscept
infect
result
show
lower
mrna
express
pe
patient
suggest
decreas
macmedi
cell
lysi
infect
cell
pe
patient
detect
gene
express
complement
receptor
fig
result
show
integrin
integrin
mrna
significantli
upregul
pe
patient
thu
interact
complement
effector
molecul
receptor
enhanc
gene
express
sever
complement
regul
also
examin
present
studi
fig
result
show
mrna
express
also
known
decay
acceler
factor
daf
significantli
increas
howev
mrna
express
factor
significantli
decreas
factor
h
regul
complement
activ
inhibit
activ
convertas
bind
chain
mac
complex
format
protect
host
cell
macmedi
lysi
thu
upregul
mrna
suggest
inhibit
macmedi
lysi
pe
patient
howev
present
studi
unclear
whether
caus
upregul
mrna
inherit
acquir
report
factor
defici
associ
recurr
bacteri
infect
present
studi
factor
mrna
express
downregul
pe
patient
compar
control
suggest
pe
patient
suscept
bacteri
infect
result
show
mrna
express
variou
compon
receptor
regul
complement
pathway
unbalanc
pe
patient
indic
function
segment
enhanc
reduc
defici
complement
activ
defend
pathogen
innat
immun
system
mainli
compris
complement
protein
phagocyt
nk
cell
wherea
adapt
immun
system
consist
cell
b
cell
produc
antibodi
stimul
previous
report
mrna
express
gene
associ
nk
cell
downregul
pe
patient
also
report
transmiss
electron
microscopi
show
rodlik
bacteria
patient
recurr
pedvt
indic
phagocyt
defici
pe
patient
addit
previou
studi
show
decreas
number
cd
cell
cd
cell
imbal
cd
cd
ratio
patient
acut
pe
cteph
respect
present
studi
sever
complement
earli
compon
classic
pathway
altern
pathway
complement
receptor
mrna
significantli
upregul
suggest
complement
activ
pe
patient
howev
mrna
express
sever
compon
mbl
pathway
format
mac
significantli
downregul
suggest
defect
reduc
complement
function
pe
patient
conclus
specul
exist
defici
innat
adapt
immun
pathogen
prevent
elimin
invad
circul
blood
pathogen
activ
coagul
system
directli
inflamm
indirectli
lead
occurr
symptomat
vte
final
occurr
symptomat
vte
may
associ
infect
condit
immun
defici
none
author
declar
exist
conflict
interest
